RH, Fineman JR. The role of nitric oxide synthase-derived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 293: H1491-H1497, 2007. First published May 18, 2007; doi:10.1152/ajpheart.00185.2007.-Congenital cardiac defects associated with increased pulmonary blood flow (Q p) produce pulmonary hypertension. We have previously reported attenuated endothelium-dependent relaxations in pulmonary arteries (PA) isolated from lambs with increased Q p and pulmonary hypertension. To better characterize the vascular alterations in the nitric oxide-superoxide system, 12 fetal lambs underwent in utero placement of an aortopulmonary vascular graft (shunt). Twin lambs served as controls. PA were isolated from these lambs at 4 -6 wk of age. Electron paramagnetic resonance spectroscopy on fourth-generation PA showed significantly increased superoxide anion generation in shunt PA that were decreased to control levels following inhibition of nitric oxide synthase (NOS) with 2-ethyl-2-thiopseudourea. Preconstricted fifth-generation PA rings were relaxed with a NOS agonist (A-23187), a nitric oxide donor [S-nitrosyl amino penicillamine (SNAP)], polyethylene glycol-conjugated superoxide dismutase (PEG-SOD), or H 2O2. A-23187-, PEG-SOD-, and H2O2-mediated relaxations were impaired in shunt PA compared with controls. Pretreatment with PEG-SOD significantly enhanced the relaxation response to A-23187 and SNAP in shunt but not control PA. Inhibition of NOS with nitro-L-arginine or scavenging superoxide anions with tiron enhanced relaxation to SNAP and inhibited relaxation to PEG-SOD in shunt PA. Pretreatment with catalase inhibited relaxation of shunt PA to A-23187, SOD, and H 2O2. We conclude that NOS catalyzes the production of superoxide anions in shunt PA. PEG-SOD relaxes shunt PA by converting these anions to H 2O2, a pulmonary vasodilator. The redox environment, influenced by the balance between production and scavenging of ROS, may have important consequences on pulmonary vascular reactivity in the setting of increased Q p.
nary vasodilation, and adults with advanced pulmonary vascular disease have decreased gene expression of nitric oxide synthase (NOS) in the pulmonary vasculature (6, 13) . More recent investigations have demonstrated a role for oxidative stress in the endothelial dysfunction associated with various vascular disorders, and thus reactive oxygen species (ROS) scavenging is a potential therapeutic strategy. However, the role of oxidative stress in the pulmonary vascular abnormalities associated with increased pulmonary blood flow, and the physiological effects of scavenging ROS in this setting, are unresolved.
Previously (25) , we established a model of a congenital cardiac defect with increased pulmonary blood flow, using the placement of a large aortopulmonary vascular graft in the late-gestation fetal lamb. In the postnatal period, these lambs (shunt) display morphological and physiological features that mimic the human disease. With this model, we have demonstrated a selective impairment of endothelium-dependent pulmonary vasodilation in both intact shunt lambs and isolated pulmonary arteries (PA) harvested from shunt lambs, suggestive of decreased agonist-induced nitric oxide (NO) activity (3, 26, 31) . However, shunt lambs also have increased endothelial NOS (eNOS) protein and mRNA levels (3) . An uncoupling of eNOS, which can occur under conditions of decreased precursor and cofactor availability, resulting in the preferential production of superoxide anion over NO, may explain this paradigm of impaired endothelium-dependent vasodilation but increased eNOS gene expression (19, 21) . In fact, we have previously demonstrated that superoxide dismutase (SOD), which catalyzes the dismutation of superoxide to hydrogen peroxide (H 2 O 2 ), normalized endothelium-dependent relaxation in the PA of shunt lambs, implicating superoxide anion in the altered reactivity (31) . In addition, with the use of whole lung biopsies, we demonstrated that NOS is a source of superoxide production in shunt lambs. However, the role of NOS in the production of ROS in the pulmonary vasculature, as well as the role of ROS in altered pulmonary vascular reactivity under conditions of increased pulmonary blood flow, remain to be clarified.
Thus the objectives of the current study were 1) to evaluate superoxide anion production and the role of NOS in its generation in shunt-isolated PA; 2) to confirm the effect of SOD supplementation and NOS inhibition on the relaxation to eNOS agonists and NO donors in PA isolated from shunt and control lambs; and 3) mainly to determine the relaxation effects of a membrane-permeable form of SOD in both control and shunt PA and its mechanism of action.
METHODS
The following protocols and procedures were approved by the Institutional Animal Care Committee at the State University of New York at Buffalo. Twelve mixed-breed time-dated pregnant ewes were obtained from Swartz Family Farm (Attica, NY). At ϳ139 days gestation (term ϳ 145 days), an 8-mm Gore-Tex vascular graft was placed between the fetal aorta and pulmonary artery as previously described (25) . The fetus was placed back in the uterus. Four to six weeks after spontaneous delivery (mean age, 5.4 Ϯ 0.24 wk), the shunt lambs were killed by rapid exsanguination under pentobarbital anesthesia. Thirteen control lambs (usually twin/triplet controls) were also studied for comparison.
In vivo electron paramagnetic resonance measurement of superoxide anions. Given the millisecond-range half-life of superoxide in situ, electron paramagnetic resonance (EPR) assay involves the approach of using a comparatively specific superoxide spin-trap, 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethyl pyrrolidine HCl (CMH hydrochloride; Axxora) (8, 9, 11, 16, 18) , to generate a stable chemical product by a general method that we have used previously with in vitro cell cultures (35, 36) . Approximately 0.2 g of tissue was sectioned from fresh-frozen samples of fourth-generation PA and was immediately immersed in either normal EPR buffer [PBS supplemented with 5 M diethydithiocarbamate (Sigma-Aldrich) and 25 M desferrioxamine (Sigma-Aldrich)]. To determine both specificity and origin of superoxide, additional sample groups from both control and shunt lambs were immersed in either EPR buffer supplemented with either 100 U/ml membrane-permeable form of SOD [polyethylene glycol-conjugated SOD (PEG-SOD)] to determine the superoxide specificity of CMH or 100 M 2-ethyl-2-thiopseudourea (ETU), a specific inhibitor of NOSs (12, 28) , to ascertain the relative contribution of uncoupled NOSs to overall superoxide production. All samples were incubated for 30 min on ice, then homogenized for 30 s with a VWR PowerMAX AHS 200 tissue homogenizer. Following incubation, samples were analyzed for protein content by using Bradford analysis (Bio-Rad). Sample volumes were then adjusted with EPR buffer plus 25 mg/ml CMH hydrochloride to achieve equal protein content and a final CMH concentration of 5 mg/ml. Samples were further incubated for 60 min on ice and then were centrifuged at 14,000 g for 15 min at room temperature. Supernatant from each sample (35 l) was loaded into a 50-l capillary tube and was analyzed with a MiniScope MS200 ESR (Magnettech, Berlin, Germany) at a microwave power of 40 mW, modulation amplitude of 3,000 mG, and modulation frequency of 100 kHz, with a magnetic strength of 333.95-339.94 mT. Resulting EPR spectra were analyzed by using ANALYSIS v.2.02 software (Magnettech), whereby the EPR maximum and minimum spectral amplitudes for the 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethyl pyrrolidine (CM) ⅐ superoxide spin-trap product waveform were quantified. Experimental groups were then compared for differences in amplitude by using statistical analysis.
Isolated PA studies. Fifth-generation PA (inner diameters of ϳ1 mm) were dissected, isolated, and cut into rings as described previously (30) . Rings were suspended in water-jacketed chambers filled with aerated (94% O 2-6% CO2), modified Krebs-Ringer solution (in mM: 118 sodium chloride, 4.7 potassium chloride, 2.5 calcium chloride, 1.2 magnesium sulfate, 1.2 potassium biphosphate, 25.5 sodium bicarbonate, and 5.6 glucose). A continuous recording of isometric force generation was obtained by tying each vessel ring to a force-displacement transducer (model UC2; Statham Instruments, Hato Rey, PR) that was connected to a recorder (Gould Instrument Systems, Valley View, OH). After the arterial rings were mounted, they were allowed to equilibrate for 20 min in the bathing solution. A micrometer was used to stretch the tissues repeatedly in small increments over the following 45 min until resting tone remained stable at a passive tension of 0.8 g. Preliminary experiments determined that this procedure provided optimal length for generation of active tone to exogenous norepinephrine.
The following pharmacological agents were used: indomethacin, dl-propranolol, norepinephrine hydrochloride (NE), calcium ionophore A-23187, and NO donor S-nitrosyl amino penicillamine (SNAP), PEG-SOD, PEG-catalase, H2O2, tiron, and the NOS antagonist, N -nitro-L-arginine (L-NNA). All drugs were obtained from Sigma-Aldrich. SNAP was dissolved first in a small quantity of DMSO and then diluted in distilled water. Indomethacin was dissolved in ethanol, and L-NNA was dissolved in warmed Krebs solution. All other drugs were dissolved in distilled water. Ethanol and DMSO, at the concentrations used in these experiments, did not alter the preexisting tone of the PA.
Isolated PA were pretreated with indomethacin (10 Ϫ5 M) to prevent the formation of vasoactive prostaglandins and propranolol (10 Ϫ6 M) to block ␤-adrenergic receptors. The arteries were first constricted with increasing doses of NE (10 Ϫ8 -10 Ϫ6 M) and were relaxed with increasing concentrations of either A-23187 (10 Ϫ8 -10
, PEG-SOD (0.75 U/ml to 75 U/ml), or H 2O2 (10 Ϫ6 -10 Ϫ4 M). According to protocol, some vessels were pretreated with L-NNA (10 Ϫ3 M, to block NOS), tiron (10 Ϫ5 M, to scavenge superoxide anions), PEG-catalase (1,200 U/ml), or PEG-SOD (37.5 U/ml). These experiments were carried out in a darkened room due to the light sensitivity of L-NNA.
Statistical analysis. All data are expressed as means Ϯ SE, with n representing the number of animals studied. Statistical comparisons of the curves were performed with repeated-measures ANOVA as appropriate. Statistical analysis was performed with StatView software (Abacus Concepts, Berkley, CA). Significance was accepted at P Ͻ 0.05.
RESULTS
Superoxide anion production is higher in shunt PA compared with control PA. The waveform amplitude by EPR inhibitable by PEG-SOD was significantly higher in shunt PA compared with control PA (Fig. 1A) . In shunt PA, pretreatment with PEG-SOD decreased the amplitude to control levels, suggesting specific quenching of superoxide anions by PEG-SOD. Pretreatment of control PA with PEG-SOD had no effect.
Superoxide anion production in shunt PA is decreased by NOS inhibition. Pretreatment with NOS inhibitor ETU significantly reduced the amplitude in shunt PA (Fig. 1B) . This indicates that NOS is a significant source of superoxide anions in shunt PA. Pretreatment of control PA with ETU had no effect. The ETU-inhibitable component of this waveform amplitude is significantly higher in shunt PA compared with controls.
SOD enhances NO-mediated relaxation in shunt PA. We have previously reported that the relaxation response to NOS stimulant A-23187 is impaired in shunt PA (2, 31) . Pretreatment with PEG-SOD significantly enhanced the relaxation response in shunt but not control PA ( Fig. 2A) . Similarly, NO donor SNAP relaxation is significantly enhanced by pretreatment with PEG-SOD in shunt PA (Fig.  2B) . Pretreatment with PEG-SOD also enhanced the relaxation response to SNAP in control PA, but this effect failed to reach significance (P ϭ 0.06).
Superoxide anion scavenger tiron enhances exogenous NObut not NOS-mediated relaxation in shunt PA. Pretreatment of shunt PA with superoxide scavenger tiron significantly enhanced the relaxation response to SNAP. Similar to PEG-SOD, tiron did not enhance SNAP-mediated relaxation in control PA (Fig. 3B) . In sharp contrast, pretreatment with tiron did not significantly alter the impaired A-23187-mediated relaxation in shunt PA and decreased A-23187-mediated relaxation in control PA (Fig. 3A) . PEG-SOD relaxed control PA significantly better than shunt PA, and both these relaxations were significantly inhibited by pretreatment with tiron (Fig. 3C) .
NOS inhibition enhances NO-mediated relaxation in shunt PA. A nonspecific NOS inhibitor, L-NNA, as expected, blocked relaxation to A-23187 in both shunt and control PA. However, L-NNA enhanced the relaxation to SNAP in shunt but not control PA (Fig. 4B) , similar to that observed following pretreatment with SOD and tiron. Relaxation of both control and shunt PA to PEG-SOD were significantly inhibited by pretreatment with L-NNA (Fig. 4C) .
Pretreatment with catalase inhibits relaxation to A-23187. Pretreatment with PEG-catalase significantly inhibited the relaxation to A-23187 and PEG-SOD in both control and shunt PA and almost completely blocked relaxation to these agents in shunt PA (Fig. 5, A and C) . SNAP-mediated relaxation was not altered by PEG-catalase (Fig. 5B) . H 2 O 2 relaxed control PA significantly better than shunt PA, and both these relaxations were completely blocked by pretreatment with PEG-catalase (Fig. 5D) .
DISCUSSION
Together, these data indicate that NOS-generated superoxide and subsequent H 2 O 2 production are integral to the mechanisms mediating PA function under conditions of increased pulmonary blood flow. We found that superoxide levels are increased in shunt PA and that NOS is a source of superoxide production. This suggests that NOS is uncoupled, such that with stimulation it produces superoxide in preference to NO. Thus diminished NO production by NOS likely contributes in part to attenuated agonist-induced endothelium-dependent relaxation in PA. However, the role of superoxide appears to be more complicated. Scavenging superoxide in a manner that does not lead to H 2 O 2 production does not attenuate impaired endothelium-dependent relaxation in PA, whereas the dismutation of superoxide to H 2 O 2 does, suggesting that the latter Fig. 2 . Concentration-response curves to endothelial nitric oxide synthase stimulant and calcium ionophore A-23187 (A) and nitric oxide donor S-nitrosyl amino penicillamine (SNAP; B) in PA isolated from 4-to 6-wk-old control lambs an shunt lambs. All PA were pretreated with indomethacin (10 Ϫ5 M) and propranolol (10 Ϫ6 M) and were contracted with norepinephrine (NE; 3 ϫ 10 Ϫ7 M). Some PA were pretreated with 37.5 units/ml of PEG-SOD. There was a tendency toward enhanced relaxations in control PA following pretreatment with PEG-SOD (P ϭ 0.06). *P Ͻ 0.05 compared with control and †P Ͻ 0.05 compared with shunt. Data were obtained from 13 control and 12 shunt lambs. effect is mediated by H 2 O 2 -induced relaxation. At the same time, superoxide scavenging, independent of H 2 O 2 , augments endothelium-independent relaxation to exogenous NO, suggesting that superoxide may decrease bioavailable NO and thus may also contribute to impaired shunt PA relaxation. With the use of fluorescent dye techniques, we previously demonstrated that peripheral lung samples taken from shunt lambs have increased levels of superoxide anion (14) . In addition, treatment with NOS antagonists before staining with superoxide-sensitive dyes decreased fluorescence, suggesting that NOS was a potential source of superoxide in shunt peripheral lung. However, this technique could not isolate the precise site of superoxide production within the lung (14) . In the current study, we used EPR to demonstrate for the first time that superoxide anion generation is increased in the PA isolated from shunt lambs. In addition, since NOS antagonists normalize superoxide anion levels, our data suggest that the increased production in the vessels is dependent on endogenous NOS activity (Fig. 1) . It should be noted that these determinations reflect basal amounts of superoxide anion generation, as opposed to generation that occurs on agonist stimulation. Further studies are warranted to measure superoxide generation with agonist stimulation. Impairment of endothelium-dependent vasodilation is a hallmark of endothelial dysfunction. Endothelium-dependent vasodilators, such as acetylcholine and the calcium ionophore A-23187, induce vasodilation by the activation of NOS and the liberation of NO. Several years ago, Celemajer et al. (6) demonstrated an attenuated pulmonary vasodilating response to acetylcholine in infants and children with congenital cardiac defects, resulting in increased pulmonary blood flow. Subsequently, we found a similar impairment of endothelium-dependent vasodilation in both the intact shunt lamb and in isolated PA harvested from shunt lambs (2, 31). In the current study, we demonstrate that stimulation of NOS generates superoxide anions, suggesting that NOS is uncoupled (Fig. 1B) . Previous studies have demonstrated that suboptimal concentrations of the precursor L-arginine and cofactors may result in uncoupling of NOS (17, 22) . The exact etiology of NOS uncoupling in this setting is unclear, but we have previously demonstrated both decreased L-arginine levels and alterations in BH 4 metabolism in shunt lambs (14, 26) . Thus the impaired relaxation to A-23187 may result, in part, from decreased NO production from NOS. Interestingly, we found that the dismutation of superoxide to H 2 O 2 by SOD pretreatment normalized A-23187-mediated relaxation in shunt PA and that scavenging superoxide anions by tiron or metabolizing H 2 O 2 with catalase inhibited relaxation to A-23187 in shunt pulmonary arteries. This suggests that H 2 O 2 plays a crucial role in SOD-mediated restoration of endothelium-dependent relaxation of shunt pulmonary arteries.
Previously, we have demonstrated that despite alterations in the downstream mediators of the NO-cGMP cascade, endothelium-independent vasodilation is intact in shunt lambs (2, 4, 31) . For example, in the intact shunt lamb, inhaled NO dilates the pulmonary circulation similar to controls. Similarly, SNAP-induced dilation is similar in PA isolated from shunt and control lambs (2, 31) . We recapitulate these data in Fig.  2B . Interestingly, the current study also demonstrates that endothelium-independent relaxations to NO donors (SNAP) are enhanced in shunt PA by pretreatment with SOD, tiron, and L-NNA. Because these agents all reduce the concentration of superoxide anions (10) either by converting them to H 2 O 2 (SOD), scavenging them (tiron), or reducing their production through inhibition of NOS (L-NNA), these data suggest that under basal conditions, exogenous NO is partly inactivated in shunt lambs by superoxide anions. This is consistent with our previous data in a lamb model of persistent pulmonary hypertension of the newborn (following in utero constriction of the ductus arteriosus), in which the pulmonary vasodilating response to inhaled NO was augmented by intratracheal administration of SOD (20) . In children with congenital heart disease and elevated pulmonary vascular resistance, the combination of oxygen and inhaled NO is thought to produce maximal pulmonary vasodilation and is therefore utilized for pre-and postoperative reactivity testing, as well as perioperative pulmonary vasodilator therapy (1, 34) . The current data suggest that the addition of ROS scavengers may augment the pulmonary vasodilating response of inhaled NO and thereby optimize its utility in this patient population. Further in vivo studies are warranted.
The exogenous administration of SOD is a promising new therapy for pulmonary vascular disease. For example, preclinical data suggest a role in the treatment of persistent pulmonary hypertension of the newborn (20, 29) , and administration in preterm neonates demonstrates its safety and potential benefit on pulmonary function (7) . Vascular relaxation to SOD is traditionally thought to be secondary to sparing endogenous NO (15, 23) . However, SOD converts superoxide anions to H 2 O 2 , a potential pulmonary vasodilator (22) . Our current data suggest that in control PA, both the above-mentioned mechanisms, i.e., sparing of NO (not inhibited by catalase) and formation of H 2 O 2 (inhibited by catalase), play an important role. However, in shunt PA, relaxation to PEG-SOD is completely blocked by catalase, suggesting that H 2 O 2 is solely responsible for this relaxation (Fig. 5, C and D) . Pretreatment with L-NNA completely blocks relaxation response to PEG-SOD in control and shunt PA (Fig. 4C) . Thus NOS appears to be a significant source of NO and superoxide anions in both control and shunt lambs.
We have previously shown (14) that superoxide but not H 2 O 2 levels are increased in 4-wk-old shunt lamb lungs without any change in SOD or catalase activity. However, administration of SOD converts these elevated superoxide anion levels to H 2 O 2 , a potential pulmonary vasodilator. In Fig. 5 , we demonstrate that H 2 O 2 induces dose-dependent relaxation in isolated PA from both control and shunt lambs. However, the effect is attenuated in shunt compared with control lambs. Previous studies in isolated rabbit lungs demonstrate that H 2 O 2 induces endothelium-independent pulmonary vasodilation via the activation of soluble guanylate cyclase and the subsequent increase in cGMP concentrations (5) . The etiology of the attenuated response in shunt lambs is unclear and warrants further study.
It should be noted that several vascular responses, including H 2 O 2 , are dependent on the oxygen environment. Many laboratories (including ours) that study isolated vessels in conventional tissue baths use a 94% oxygen and 6% CO 2 gas mixture (27, 32, 33) . The PO 2 of the buffer solution bathing the tissue is close to 500 mmHg, and PCO 2 is ϳ40 mmHg. This approach is based on the assumption that the inner core of smooth muscle cells in the vessel may be relatively hypoxic because of lack of perfusion through the vasa vasorum. We acknowledge the possibility that a high buffer PO 2 might have affected our results. However, similar conditions were used to study PA isolated from control and shunt lambs. Also, many patients with pulmonary hypertension are treated with high concentrations of oxygen, resulting in high alveolar PO 2 levels.
In summary, we demonstrate that eNOS-ROS interactions mediate the altered endothelium-dependent and -independent vascular relaxations noted in lambs with increased pulmonary blood flow. We have previously shown (14) that superoxide but not H 2 O 2 levels are increased in 4-wk-old shunt lamb lungs without any change in SOD or catalase activity. These elevated superoxide levels are due to increased production from uncoupled NOS and other sources, which include NADPH oxidase. Conversion of these elevated superoxide anion levels to a pulmonary vasodilator such as H 2 O 2 by exogenous SOD either administered by an intravascular (24) or intratracheal (20) route may normalize and/or augment pulmonary vasodilator responses. Therefore, coadministration of SOD should be considered a potential therapeutic option in the management of pulmonary hypertension with increased pulmonary blood flow associated with congenital heart disease, and it warrants further study. In addition, these data suggest that the redox environment, which is influenced by the balance between ROS production and scavenging, may have important consequences on pulmonary vascular reactivity in the setting of increased pulmonary blood flow.
GRANTS

